By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.

CAPLACIZUMAB (kap la SIZ ue mab) treats acquired thrombotic thrombocytopenic purpura (aTTP), a condition that causes blood clots and low levels of platelets in the body. It works by preventing blood cells (platelets) from clumping together to form a clot. It is a monoclonal antibody.


There are no images available for this medication.